全文获取类型
收费全文 | 961篇 |
免费 | 55篇 |
国内免费 | 59篇 |
专业分类
耳鼻咽喉 | 9篇 |
儿科学 | 49篇 |
妇产科学 | 6篇 |
基础医学 | 60篇 |
口腔科学 | 13篇 |
临床医学 | 152篇 |
内科学 | 308篇 |
皮肤病学 | 19篇 |
神经病学 | 37篇 |
特种医学 | 232篇 |
外科学 | 45篇 |
综合类 | 29篇 |
预防医学 | 44篇 |
眼科学 | 9篇 |
药学 | 35篇 |
中国医学 | 2篇 |
肿瘤学 | 26篇 |
出版年
2023年 | 2篇 |
2021年 | 10篇 |
2020年 | 3篇 |
2019年 | 3篇 |
2018年 | 17篇 |
2017年 | 7篇 |
2016年 | 6篇 |
2015年 | 18篇 |
2014年 | 20篇 |
2013年 | 27篇 |
2012年 | 25篇 |
2011年 | 20篇 |
2010年 | 26篇 |
2009年 | 22篇 |
2008年 | 16篇 |
2007年 | 57篇 |
2006年 | 17篇 |
2005年 | 23篇 |
2004年 | 23篇 |
2003年 | 25篇 |
2002年 | 17篇 |
2001年 | 12篇 |
2000年 | 12篇 |
1999年 | 16篇 |
1998年 | 51篇 |
1997年 | 36篇 |
1996年 | 62篇 |
1995年 | 45篇 |
1994年 | 41篇 |
1993年 | 50篇 |
1992年 | 15篇 |
1991年 | 14篇 |
1990年 | 25篇 |
1989年 | 38篇 |
1988年 | 41篇 |
1987年 | 38篇 |
1986年 | 29篇 |
1985年 | 30篇 |
1984年 | 19篇 |
1983年 | 12篇 |
1982年 | 12篇 |
1981年 | 22篇 |
1980年 | 19篇 |
1979年 | 7篇 |
1978年 | 9篇 |
1977年 | 15篇 |
1976年 | 7篇 |
1975年 | 9篇 |
1963年 | 1篇 |
1904年 | 1篇 |
排序方式: 共有1075条查询结果,搜索用时 15 毫秒
21.
Immunobiology of T helper cells and antigen-presenting cells in autoimmune thrombocytopenic purpura (ITP) 总被引:1,自引:0,他引:1
JW Semple 《Acta paediatrica (Oslo, Norway : 1992)》1998,87(S424):41-45
Autoimmune thrombocytopenic purpura (AITP) is a bleeding disease in which autoantibodies are directed against the individual's own platelets, resulting in enhanced Fc-mediated platelet destruction by macrophages in the reticuloendothelial system. Most research in AITP has focused on characterization of the autoantibodies, while little has been devoted to the cellular immune mechanisms leading to autoantibody production. This report summarizes the current state of the literature and argues that enhanced T helper cell/antigen-presenting cell interactions in patients with AITP are the primary stimulus for the development of antiplatelet autoantibody production. Understanding these events is important for eventually identifying disease-initiating platelet autoantigens and ultimately developing specific immunotherapies for AITP. 相似文献
22.
23.
A pedunculated aldosterone‐producing adenoma drained by an extra vein causing puzzling results of adrenal vein sampling 下载免费PDF全文
24.
Malte Lenders J?rg Stypmann Thomas Duning Boris Schmitz Stefan-Martin Brand Eva Brand 《Journal of the American Society of Nephrology : JASN》2016,27(1):256-264
Fabry disease (FD) is a progressive multisystemic disorder, treatable with recombinant enzyme replacement therapy (agalsidase). However, recent studies suggest an endogenous inhibition of agalsidase in patients with FD, as reported for other lysosomal storage diseases. To assess the clinical consequences of serum-mediated agalsidase inhibition in affected patients, we determined the agalsidase inhibition status of 168 patients (68 male) with FD and compared outcomes of inhibition-positive patients with those of inhibition-negative patients. The assessment included clinical events during time on agalsidase, determination of renal and cardiac function, and evaluation of FD-related symptoms. The frequency of serum-mediated agalsidase inhibition was 40% in agalsidase-treated males. Inhibition did not depend on the compound initially used (agalsidase-α or -β). Agalsidase inhibition was associated with higher lyso-globotriaosylceramide levels and worse disease severity scores in patients. Compared with agalsidase inhibition-negative men, agalsidase inhibition-positive men showed greater left ventricular mass (P=0.02) and substantially lower renal function (difference in eGFR of about –30 ml/min per 1.73 m2; P=0.04), which was confirmed by a longitudinal 5-year retrospective analysis. Additionally, affected patients presented more often with FD-typical symptoms, such as diarrhea, fatigue, and neuropathic pain, among others. Therefore, patients with poor clinical outcome on agalsidase should be tested for agalsidase inhibition. Future studies are warranted to determine if affected patients with FD benefit from acute reduction of anti-agalsidase antibodies or long-term immune modulation therapies to suppress agalsidase inhibition and to identify mechanisms that minimize antibody generation against agalsidase. 相似文献
25.
Suman Kundu Lennart C Karssen A Cecile JW Janssens 《European journal of human genetics : EJHG》2012,20(12):1270-1274
Various modeling methods have been proposed to estimate the potential predictive ability of polygenic risk variants that predispose to various common diseases. However, it is unknown whether differences between them affect their conclusions on predictive ability. We reviewed input parameters, assumptions and output of the five most common methods and compared their estimates of the area under the receiver operating characteristic (ROC) curve (AUC) using hypothetical data representing effect sizes and frequencies of genetic variants, population disease risk and number of variants. To assess the accuracy of the estimated AUCs, we aimed to reproduce the AUCs of published empirical studies. All methods assumed that the combined effect of genetic variants on disease risk followed a multiplicative risk model of independent genetic effects, but they either assumed per allele, per genotype or dominant/recessive effects for the genetic variants. Modeling strategy and input parameters differed. Methods used simulation analysis or analytical formulas with effect sizes quantified by odds ratios (ORs) or relative risks. Estimated AUC values were similar for lower ORs (<1.2). When AUCs were larger (>0.7) due to variants with strong effects, differences in estimated AUCs between methods increased. The simulation methods accurately reproduced the AUC values of empirical studies, but the analytical methods did not. We conclude that despite differences in input parameters, the modeling methods estimate similar AUC for realistic values of the ORs. When one or more variants have stronger effects and AUC values are higher, the simulation methods tend to be more accurate. 相似文献
26.
Non-functioning pituitary carcinomas (NFPC) are defined as tumours of adenophyseal origin with craniospinal or systemic dissemination, with the absence of a hormonal hypersecretion syndrome. These are a histologically heterogenous group of tumours, comprising gonadotroph, null cell, “silent” tumours of corticotroph, somatotroph or lactotroph cell lineages as well as plurihormonal Pit-1 tumours. NFPC are exceedingly rare, and hence few cases have been described. This review has identified 38 patients with NFPC reported in the literature. Recurrent invasive non-functioning pituitary adenomas (NFPA) were observed in a majority of patients. Various factors have been identified as markers of the potential for aggressive behaviour, including rapid tumour growth, growth after radiotherapy, gain or shift of hormone secretion and raised proliferative markers. Typically, there is a latency of several years from the original presentation with an NFPA to identification of metastases and only 5 cases reported with rapidly progressive malignant disease within 1 month of presentation. Therapeutic options include debulking surgery, radiation therapy and chemotherapy with temozolomide recommended as first line systemic treatment. Although long-term survivors are described, prognosis remains generally very poor (median survival 8 months). Improvements in molecular tumour profiling may assist in predicting tumour behaviour, guide therapeutic choices and identify novel therapies. 相似文献
27.
We have identified and molecularly characterized a novel deletion in the beta-globin gene cluster that increases fetal hemoglobin (HbF) synthesis in a 24-year-old Laotian man who is heterozygous for this mutation. The patient is asymptomatic with a mild anemia, hypochromia, and microcytosis (Ht = 39%, MCH = 22.8 pg, MCV = 71 fl), normal levels of HbA2 (3.0%) and 11.5% HbF (G gamma A gamma ratio 60 to 40), with heterocellular distribution (52% F cells). Extensive restriction endonuclease mapping defined the 5' breakpoint within the IVS II of the delta-globin gene, between positions 775 to 781 very similar to the 5' breakpoint of the Sicilian delta beta-thalassemia. However, the 3' breakpoint was localized between two Pst I sites 4.7 kb 3' of the beta- globin gene, thus ending about 0.7 kb upstream from the 3' breakpoint of the Sicilian delta beta-thalassemia. This results in a 12.5 kb deletion of DNA. It is of interest that the 5' breakpoint of the deletion residues within an AT-rich region which has been proposed as a specific recognition signal for recombination events, while the 3' breakpoint lies within a cluster of L1 repetitive sequences (formerly known as Kpn I family repeats). The presence of the 3' breakpoints of several other deletions within this region of L1 repeats also suggests that such sequences might serve as hot spots for recombination and eventually lead to thalassemia deletions. The similarity of the 5' and 3' breakpoints of these delta beta-thalassemias underscores the putative regulatory role of the deleted and juxtaposed sequences on the expression of the gamma-globin genes in adult life. 相似文献
28.
Binding of heme by glutathione S-transferase: a possible role of the erythrocyte enzyme 总被引:4,自引:0,他引:4
Human erythrocyte glutathione S-transferase activity is inhibited, probably competitively, by hemin with a Ki of 10(-7) M. It is postulated that glutathione S-transferase functions physiologically as a hemin-binding and/or transport protein in developing erythroid cells. 相似文献
29.
乐胃煎逆转胃癌前病变AgNOR及细胞图像分析 总被引:3,自引:0,他引:3
目的研究乐胃煎逆转胃癌前病变不完全结肠型肠化和/或中度异型增生的疗效.方法胃镜病理证实为不完全结肠型肠化和/或中度异型增生46例.治疗组30例用乐胃煎,对照组16例用德诺(De_Nol).治疗前后胃镜活检胃窦固定部位粘膜标本作AgNOR染色及细胞图像分析.结果乐胃煎对不完全结肠型肠化及中度异型增生总有效率均高于De_Nol,分别为72%比25%(P<005)和895%比444%(P<005).乐胃煎治疗前后,AgNOR计数分别为730±116和481±150(P<001),De_Nol组为773±092和705±102(P<001).两组治疗前后AgNOR计数差值均数相比,统计学上也有显著性差异,分别为252±154和069±048(P<001).乐胃煎组中20例作细胞图像分析,治疗后各参数(长轴、短轴、核浆比、结构异型指数等)均有不同程度的降低,有显著性差异.结论乐胃煎确有较好地逆转胃癌前病变的功效. 相似文献
30.
Nicolas K Khattar Andrew C White Aurora S Cruz Shawn W Adams Kimberly S Meyer Haring JW Nauta Dale Ding Robert F James 《Interventional neuroradiology》2021,27(3):388
Ruptured vertebrobasilar dissecting aneurysms require urgent, often challenging treatment as they have with a high re-hemorrhage rate within the first 24 hours. The patient is a 57-year-old woman who presented with severe-sudden onset headache. Further work up showed a ruptured dissecting aneurysm of the caudal loop of the posterior inferior cerebellar artery (PICA) with associated narrowing distally, in the ascending limb. The aneurysm was immediately occluded with a Woven Endobridge (WEB) device (MicroVention, Tustin, CA, USA) while flow diversion treatment of the diseased ascending limb was postponed. Follow-up angiography three months later showed complete occlusion of the aneurysm, as well as healing of the diseased distal vessel, obviating the need for further intervention. WEB embolization of a ruptured dissecting posterior circulation aneurysm provided an excellent outcome for this patient. 相似文献